Drugs & Therapy Perspectives

译名:药物与治疗视角

Drugs and Therapy Perspectives

ESCIJCR Q4

<1

2026

影响因子区间

70天

平台估算

投稿周期

0%

2025

中国作者发文占比

40000000 IRR;600 USD

费用说明

收费

期刊简介:Drugs & Therapy Perspectives promotes rational pharmacotherapy and effective disease management by publishing concise, authoritative review articles to aid drug formulary and treatment decisions, and original research articles covering all aspects of pharmacological treatment to assist healthcare professionals in providing quality patient care. It focuses on the practical application of research and best evidence for healthcare professionals working in real-world clinical settings. TheJournal includes:Reviews of pharmacological agents, disease management, adverse drug reactions and interactions, or other clinically relevant issues. These provide up-to-date guidance on the use of pharmacological agents in the real-world setting, including step-by-step patient care guidelines to aid treatment decisions, and  the differential features of drugs to enable formulary comparisons.Original research articles with a strong focus on clinical practice and real-world outcomes to assist healthcare professionals in providing quality evidence-based patient care.Therapy-in-practice articles, current opinions and commentaries giving international viewpoints on emerging issues and therapeutic approaches to specific diseases or therapeutic questions.Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Drugs & Therapy Perspectives may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.All manuscripts are subject to single-blind peer review by international experts. Letters to the Editor are welcomed and will be considered for publication.

【译文】通过发表简洁、权威的综述文章来促进合理的药物治疗和有效的疾病管理,从而帮助制定药物目录和治疗决策,并发表涵盖药物治疗所有方面的原创研究文章,以协助医疗保健专业人员提供高质量的病人护理。该期刊专注于研究在现实世界临床环境中的实际应用和最佳证据,包括药物在现实世界环境中的使用指南,以及药物差异特征的比较,以帮助制定药物目录。原创研究文章侧重于临床实践和现实世界结果,以协助医疗保健专业人员提供高质量的循证病人护理。实践中的治疗文章、当前观点和评论,提供关于特定疾病或治疗问题的国际观点和治疗方法的观点。此外,文章还可能附带附加数字功能(包括动画摘要、视频摘要、幻灯片、音频幻灯片、教学视频、信息图表、播客和动画),旨在增加期刊内容的可见性、读者数量和教育价值。此外,发表在《药物与治疗观点》的文章可能还附有通俗易懂的摘要,以帮助那些对该领域有一定了解但不是深入了解的读者理解重要的医学进展。所有稿件都由国际专家进行单盲同行评审。欢迎投稿给编辑的信件,并将考虑发表。

出版社
Adis, Springer Healthcare
语言
English
学科
ISSN
1172-0360
eISSN
1179-1977
出版频率
月刊
创刊年份
1981
投稿网址
https://www.editorialmanager.com/drtp
最近更新
2026-04-02 18:16:40
Drugs & Therapy Perspectives

指标当前值近三年趋势
JCR分区Q4
暂无
影响因子区间<1
暂无